Driving Growth Through Innovation

Driving Growth Through Innovation

Indian businesses that treat innovation as a structured operational discipline — not a quarterly offsite exercise — are compounding faster than peers in every sector. The policy environment in FY 2026-27 is the most supportive it has ever been: the IndiaAI Mission is disbursing compute infrastructure, the Anusandhan National Research Foundation (NRF) is funding applied R&D at scale, and Section 35 of the Income-tax Act still lets you deduct qualifying R&D expenditure in full. The question is no longer whether to innovate; it is whether you are structured to capture the funding, the deductions, and the IP protection that make innovation financially viable.

What Innovation Actually Means for an Indian Business in 2026

Indian SMEs and mid-market companies almost always define innovation too narrowly — a new product, a new feature, a new SKU. That definition misses the innovations that deliver the highest return on effort.

There are four types worth tracking separately:

1. Product innovation — new or materially improved offerings that open new revenue streams or justify price premiums.
2. Process innovation — changes to how you make, deliver or service that cut costs, cycle times or working-capital requirements. A distributor who moves from weekly manual reconciliation to daily automated reconciliation via Account Aggregator rails is innovating, even if nothing visible changed for the end customer.
3. Business-model innovation — shifting from one-time to subscription, from product to platform, from B2C to B2B2C. These are often the highest-leverage plays because they restructure unit economics without requiring large capex.
4. Customer-experience innovation — reducing friction at moments that matter most: onboarding, issue resolution, renewal. A 5-minute GST-compliant invoice instead of a 48-hour turnaround is experience innovation that compounds NPS year over year.

The most defensible innovations combine at least two of these types. A better product sold through a new channel with a subscription model is far harder to replicate than any single dimension alone.

Where Indian Innovators Are Winning Right Now

Several sectors have structural tailwinds that reward focused innovation investment in FY 2026-27:

• Vertical AI: Domain-specific large-language-model deployments for legal contract review, radiology triage, crop-disease identification, and credit underwriting for thin-file borrowers. These win because context-specificity beats general models at narrow tasks — and Indian enterprises pay for accuracy, not novelty.
• Frugal manufacturing: EV two-wheeler components, agri-machinery attachments, diagnostic medical devices, and low-cost solar microinverters. The Bharat market demands 40-60% cost reductions versus global benchmarks; engineers who achieve that without compromising safety create defensible niches.
• Climate-tech: Green-hydrogen pilot plants, used-lithium-ion battery recycling (PLI-linked), and decentralised solar + storage for commercial rooftops. Government procurement commitments provide revenue visibility that de-risks early-stage bets.
• ONDC and Account Aggregator stack plays: Logistics orchestration, embedded lending, and vernacular-commerce interfaces built on top of open digital infrastructure. The rails are free; the innovation is in the application layer.
• Localised SaaS: Accounting, HRMS, and inventory tools built natively for Bharat-language users, UPI-native payments, and GST-compliant workflows. Large SaaS incumbents consistently under-serve Tier 2 and Tier 3 buyers — this is a long structural gap.

Funding Your Innovation Pipeline: Four Channels You May Not Be Using

Venture capital should be the last item on the funding checklist for innovation-stage projects, not the first. Several non-dilutive or low-dilution options are available in FY 2026-27.

Startup India Seed Fund Scheme (SISFS)

Managed by DPIIT and routed through approved incubators, SISFS provides:

• Proof-of-concept grants of up to Rs. 20 lakh per startup
• Prototype and pilot grants of up to Rs. 50 lakh
• Market-entry loans or convertible debentures of up to Rs. 75 lakh for revenue-generating startups

The scheme runs on a rolling basis. Applications go to DPIIT-registered incubators; the incubator selection committee makes disbursement decisions. Your startup must be DPIIT-recognised (apply via the Startup India portal: startupindia.gov.in) and not more than two years old at the time of application. SISFS funds are not equity — the grants are non-repayable. This makes them highly valuable for de-risking the earliest phase of R&D.

IndiaAI Mission: Compute Credits and Infrastructure Access

The IndiaAI Mission carries a Rs. 10,372 crore allocation across five years, of which a significant portion goes to the IndiaAI Compute Facility (IAICF). By FY 2026-27, India has operational GPU compute capacity accessible to startups, academic institutions, and deep-tech companies through the india.ai portal. Eligible entities can apply for subsidised compute time for training and fine-tuning AI models. If you are building vertical AI (diagnostics, agri, legal, credit) and need GPU hours that would otherwise cost Rs. 5-15 lakh per month on commercial cloud, IAICF access is material — apply through the designated application window announced by the Ministry of Electronics and Information Technology (MeitY).

BIRAC, TIDE 2.0 and State Innovation Funds

• BIRAC (Biotechnology Industry Research Assistance Council): The Biotechnology Ignition Grant (BIG) offers up to Rs. 50 lakh for early-stage biotech and medtech innovators; the SPARSH scheme funds social innovation. Applications through birac.nic.in.
• TIDE 2.0 (MeitY): Provides up to Rs. 5 crore to approved incubators, who support portfolio startups with seed grants of Rs. 10-20 lakh. Useful for IT-led and IoT innovation.
• State funds: T-Hub (Telangana), K-Tech (Karnataka), Maharashtra Innovation Society, and Kerala Startup Mission each run grant programmes and subsidised incubation. Amounts typically range from Rs. 5 lakh to Rs. 1 crore. Check the respective state's IT department portal for current open calls.

NRF Grants for Applied Research

The Anusandhan NRF, established under the Anusandhan NRF Act 2023 with a five-year budget of Rs. 50,000 crore (with Rs. 36,000 crore expected from private and industry contributions), is now operational and accepting applications for collaborative research projects between industry and research institutions. If you have a manufacturing or product-led business with a genuine R&D problem, partnering with an IIT, NIT, or approved research institution on an NRF-funded project can fund the research while also generating IP jointly owned by your business. Explore open calls at anrf.in.

Claiming the Section 35 R&D Deduction in AY 2027-28

Section 35 of the Income-tax Act 1961 provides deductions for scientific research expenditure. Understanding the three relevant sub-sections saves material tax — particularly for companies with dedicated R&D facilities.

What Section 35(2AB) Covers

Section 35(2AB) applies to companies engaged in the business of bio-technology or in the business of manufacture or production of any article or thing (excluding items in the Eleventh Schedule). If the company has a DSIR-approved in-house R&D facility (approval from the Department of Scientific and Industrial Research), both revenue and capital expenditure on in-house R&D are deductible at 100% in the year of expenditure.

The critical word is capital. Revenue expenditure (salaries, consumables, test materials) would have been deductible anyway as a business expense. The unique value of Section 35(2AB) is that capital expenditure — R&D lab equipment, instruments, dedicated R&D building — is deductible 100% upfront, instead of being depreciated over several years under the normal depreciation schedule.

> Current rate: The weighted deduction, which was 200% until AY 2017-18 and reduced to 150% from AY 2018-19, was further reduced to 100% effective AY 2021-22 by the Finance Act 2020. This 100% rate continues for AY 2027-28 subject to any amendment by Finance Act 2026 — verify the final act before filing.

DSIR approval process: File Form 3CK online through the DSIR portal. DSIR conducts a site visit and approves the R&D facility. Without DSIR approval, Section 35(2AB) cannot be claimed — companies often miss this step and lose the deduction entirely.

Worked Example: Rs. 60 Lakh R&D Budget, FY 2026-27

Assume a DSIR-approved manufacturing company spends Rs. 60 lakh on its in-house R&D project in FY 2026-27:

Without Section 35(2AB) (normal provisions):

• Revenue expenditure deduction in FY 2026-27: Rs. 25 lakh
• Capital depreciation at 15% on Rs. 35 lakh = Rs. 5.25 lakh
• Total deduction Year 1: Rs. 30.25 lakh → Tax saved @ 25% base rate = Rs. 7.56 lakh

With Section 35(2AB):

• 100% deduction on both revenue and capital in FY 2026-27: Rs. 60 lakh
• Tax saved @ 25%: Rs. 15 lakh
• Incremental benefit in Year 1: Rs. 7.44 lakh — essentially a cash-flow acceleration on the capital portion, available to redeploy in Year 2 experiments.

On a Rs. 60 lakh R&D budget, that is over Rs. 7 lakh of freed-up cash flow — more than enough to fund a meaningful follow-on experiment.

Payments to External Research Institutions: Section 35(1)

If you pay an approved research association, university, or institution, Section 35(1)(ii) provides a 100% deduction. Companies not eligible for Section 35(2AB) (e.g., service businesses) can still claim deductions on payments to approved bodies. Check the list of approved institutions on the Income Tax India portal before making payments — the approval status can change.

Protecting What You Build: IP Strategy That Fits Your Stage

Building IP protection in parallel with R&D — not after launch — is the discipline that separates businesses with durable moats from those that invest in innovations competitors simply copy.

DPIIT IPR Fast-Track for Recognised Startups

DPIIT-recognised startups receive two concrete advantages under the Startup India IPR scheme:

1. 80% rebate on patent filing fees (as against the fees payable by companies). On a complete patent specification filing where the standard fee is Rs. 16,000, a startup pays Rs. 3,200.
2. Expedited examination: Applications tagged as startup applications are examined on a priority basis — typical examination timelines have been significantly reduced compared to the general queue.

File through the IP India portal (ipindia.gov.in). Attach your DPIIT recognition certificate. Use a registered patent agent for drafting — the quality of claims drafting determines the commercial value of the patent, not just whether it is granted.

File the Provisional First; Polish Later

A provisional patent application fixes your priority date — the date from which your invention is protected against prior art claims by competitors. You have 12 months from the provisional filing date to file the complete specification. This allows you to launch a product, test market response, and then decide whether to commit to the full prosecution cost — without losing your date.

Patents vs. Trade Secrets: A Practical Framework

Not every process innovation should be patented. A patent discloses the invention to the public in exchange for a time-limited monopoly. A trade secret provides perpetual protection as long as the secret is maintained — but it fails completely if a competitor independently discovers the same process.

Use this rule of thumb:

• Patent if: the innovation is visible in the product (reverse-engineerable by a competitor), the market window is less than 20 years, and you want licensing revenue.
• Trade secret if: the innovation is embedded in your operational process (not visible in the product), you can maintain genuine secrecy through access controls and NDAs, and competitors are unlikely to independently discover it.

Many frugal manufacturing processes are better protected as trade secrets than as patents. Software algorithms that sit inside a SaaS backend are strong candidates for trade-secret protection.

Building the Innovation Operating System

Innovation without operating structure produces sporadic wins and chronic waste. An innovation operating system has five components:

1. A standing innovation backlog: A visible, prioritised list of innovation hypotheses accessible to the leadership team — not buried in a product manager's Notion board. Review it monthly.
2. Time-boxed experiments: Each experiment gets a fixed window (typically 4-8 weeks) and a fixed budget. At the end of the window, the experiment either progresses to a larger stage or is killed. No extensions without a written case.
3. Cross-functional sponsorship: Every experiment must have a business-function owner (sales, operations, finance) alongside the technical lead. This forces market-problem grounding and accelerates commercialisation.
4. Explicit kill criteria: Defined before the experiment starts — not after results look weak. "If we cannot achieve 30% trial-to-repeat conversion by week 6, we stop." Kill criteria protect resources and reduce the political difficulty of stopping failing projects.
5. Quarterly innovation review tied to capital allocation: Innovation budgets should be discussed alongside operating budgets, not as a separate line item in an annual strategy offsite. Quarterly review keeps the pipeline current and aligned to business priorities.

One practical implementation: set aside 10-15% of discretionary opex as an "innovation pool" each quarter. Allocate it through a lightweight internal pitch process — two-page memos, five-minute presentations, committee decision within one week. This prevents budget-by-inertia, where resources flow to existing projects simply because they existed last quarter.

Customer Co-Creation as a Structured Method

Some of India's highest-ROI innovations have come not from internal R&D but from structured customer co-creation. The mechanics are straightforward and underused.

Quarterly innovation forums: Invite 8-12 customers (mix of tenure, segment, and use case) to a half-day session. Sign appropriate NDAs. Share your forward-looking problem statements, not just your roadmap. Ask customers what workarounds they are currently building themselves — those workarounds often reveal the product's most painful gaps.

Private beta with paying customers: Customers who pay — even at a discount — for unfinished features are self-selecting for problem severity. Their feedback is higher signal than that of customers given free access. Require structured feedback in exchange for the discount: weekly check-ins, structured surveys, willingness to be interviewed by the product team.

Enterprise customer advisory boards: For B2B and B2B2C businesses, a board of 6-10 enterprise customers who meet quarterly shapes product direction and generates reference relationships for later commercial acceleration. Advisory board members are not paid; they participate because they get meaningful influence over a product that matters to their business.

Co-creation reduces wasted R&D spend by front-loading customer validation before significant capital is committed. It also compresses the time from experiment to commercial traction because reference customers are already embedded in the product.

Common Mistakes and How to Fix Them

The following failure modes appear repeatedly across Indian innovation programmes — recognising them early saves significant capital.

• Technology-first, problem-second: Deploying generative AI, blockchain, or AR/VR because the technology is fashionable rather than because a specific customer problem demands it. Fix: Every experiment must begin with a written problem statement and a named customer who experiences the problem.
• Underfunded experiments: Running ten Rs. 2 lakh pilots when one Rs. 20 lakh pilot would generate a real answer. Under-resourced experiments produce ambiguous results that keep zombie projects alive. Fix: Fund fewer bets, fund them properly, kill clearly.
• No kill criteria: An experiment started without exit conditions will run indefinitely on political momentum. Fix: Document kill criteria in the experiment brief before approval. Make the kill decision automatic when criteria are breached, not discretionary.
• Missing the DSIR approval before R&D spend: Companies spend on in-house R&D in Year 1, apply for DSIR approval retrospectively, and find that the deduction under Section 35(2AB) cannot be claimed for expenditure incurred before the approval date. Fix: Apply for DSIR facility approval before incurring R&D capex.
• Filing complete patent specifications first: Many first-time filers skip the provisional application and file a complete specification directly, losing the 12-month window to observe market response before committing to prosecution costs. Fix: Always start with a provisional filing on IP India portal.
• Single-channel innovation funding: Relying exclusively on equity capital to fund R&D when non-dilutive options (SISFS, BIRAC, TIDE 2.0, NRF, Section 35 deductions) can fund 30-50% of the same project at zero equity cost. Fix: Audit your innovation spend against available non-dilutive options before raising a round.

Measuring the ROI of Innovation

Innovation programmes die in budget reviews when they cannot demonstrate financial contribution. Build these metrics into your quarterly board reporting:

• New-product vitality index: Percentage of current revenue derived from products or services launched in the last 24 months. A healthy innovation pipeline sustains this at 20-30% for fast-moving businesses.
• Gross-margin uplift from process innovations: Track the pre- and post-innovation cost structure for each completed process experiment. A logistics process change that cuts Rs. 8 per shipment on 50,000 monthly shipments is Rs. 4.8 lakh saved monthly — make it visible.
• Innovation-pipeline contribution to revenue forecast: What share of your next-12-month revenue projection comes from innovations currently in experiment or early commercialisation stages?
• Kill cost of failed experiments: Report this separately and without shame. A Rs. 12 lakh experiment killed at week 6 is not a failure — it is a Rs. 12 lakh investment in learning that prevents a Rs. 1.2 crore misallocation at full scale. Mature companies expect 60-70% of experiments to fail; the discipline is in failing cheaply.

Report these four metrics alongside revenue, EBITDA, and working capital every quarter. This embeds innovation performance into the management rhythm rather than keeping it siloed in a product or strategy function.

Key Takeaways

• Innovation is four things, not one: product, process, business model, and customer experience. Track them separately; the highest-leverage plays combine at least two.
• Non-dilutive funding is available and underused: SISFS (up to Rs. 75 lakh), BIRAC BIG (up to Rs. 50 lakh), IndiaAI compute credits, and NRF collaborative grants can fund early-stage R&D at zero equity cost.
• Section 35(2AB) benefits capital R&D expenditure: With DSIR approval in place before incurring expenditure, you deduct lab equipment and instruments 100% upfront in the year of spend rather than depreciating over years — material cash-flow benefit on any R&D capex above Rs. 20-25 lakh.
• File the provisional patent before the launch: The priority date is the asset. The 80% DPIIT fee rebate for recognised startups makes early filing low-cost.
• Kill criteria must be written before experiments are approved: Innovation programmes that cannot kill failing projects consume resources and produce learned helplessness about R&D investment.
• Customer co-creation compresses time-to-traction: Paying beta customers who give structured feedback are more valuable than large free-trial cohorts with passive behaviour.
• Measure innovation's financial contribution every quarter: New-product vitality index, process gross-margin uplift, and pipeline revenue contribution keep innovation on the P&L agenda, not just the strategy deck.